Texas (May 23, 2013) Wax Ink has issued a Loss of Investment Interest rating for IDEXX Laboratories, Inc. (Nasdaq: IDXX) based on a recent baseline equity review which placed fair value between $48-$57.
The recent close of $83.37 is approximately 190% above the fair value buy target for the stock and approximately 41% above the fair value close target for the stock. The recent close is also 12% below analysts' $94.50 median target for the stock.
The recent close represents a 00% increase in price since the last baseline equity review was conducted in May 2013.
The stock currently has a trailing twelve-month PE Ratio of 20, and a PEG Ratio of 1.9 basis estimated forward earnings growth of 11%.
In the past 52 weeks, share prices have moved between a high of $101.18 and a low of $81.30, placing equilibrium at $89.84.
With the recent close, the stock is trading 21% below the 52 week high, 3% above the 52 week low, and 8% below equilibrium, on an average daily trading volume of 474 thousand shares.
IDEXX Laboratories, Inc. develops, manufactures, and distributes various products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets worldwide.
The company competes with Abaxis, Inc., Heska Corporation, and VCA Antech Inc.
All valuations are based on the listed company's most recent SEC annual filing, and all prices are per share.
Wax Ink currently has no investment position in the company mentioned in this alert.
Wax Ink is a baseline equity research company comprised of individual investors, NOT licensed or registered with ANY government agency.
For use by Accredited Investors as defined under Title 17, CFR §230.500, Regulation D
Copyright © 2013 Wax Ink
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.